The Discounted Cash Flow (DCF) valuation of Evrofarma SA (EVROF.AT) is 2.29 EUR. With the latest stock price at 1.94 EUR, the upside of Evrofarma SA based on DCF is 18.1%.
Based on the latest price of 1.94 EUR and our DCF valuation, Evrofarma SA (EVROF.AT) is a buy. buying EVROF.AT stocks now will result in a potential gain of 18.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.7% | 7.5% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 1.43 - 4.28 | 2.29 |
| Upside | -26.2% - 120.7% | 18.1% |